Drug Profile
Research programme: microbiota restoration therapy - Rebiotix
Alternative Names: RBX 6376; RBX 8225; RBX2477Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Rebiotix
- Class
- Mechanism of Action Gastrointestinal microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatic encephalopathy; Infections; Inflammatory bowel diseases; Ulcerative colitis
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Hepatic-encephalopathy in USA
- 28 Aug 2020 No recent reports of development identified for preclinical development in Infections in USA
- 28 Aug 2020 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in USA